Does ARIPIPRAZOLE Cause Salivary hypersecretion? 497 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 497 reports of Salivary hypersecretion have been filed in association with ARIPIPRAZOLE (Aripiprazole). This represents 0.8% of all adverse event reports for ARIPIPRAZOLE.
497
Reports of Salivary hypersecretion with ARIPIPRAZOLE
0.8%
of all ARIPIPRAZOLE reports
25
Deaths
225
Hospitalizations
How Dangerous Is Salivary hypersecretion From ARIPIPRAZOLE?
Of the 497 reports, 25 (5.0%) resulted in death, 225 (45.3%) required hospitalization, and 23 (4.6%) were considered life-threatening.
Is Salivary hypersecretion Listed in the Official Label?
Yes, Salivary hypersecretion is listed as a known adverse reaction in the official FDA drug label for ARIPIPRAZOLE.
What Other Side Effects Does ARIPIPRAZOLE Cause?
Drug ineffective (5,566)
Off label use (5,473)
Product use in unapproved indication (4,792)
Weight increased (4,636)
Anxiety (3,076)
Suicide attempt (2,796)
Suicidal ideation (2,618)
Condition aggravated (2,157)
Insomnia (2,147)
Akathisia (2,107)
What Other Drugs Cause Salivary hypersecretion?
CLOZAPINE (1,349)
RISPERIDONE (485)
OLANZAPINE (449)
QUETIAPINE (299)
CARBIDOPA\LEVODOPA (248)
HALOPERIDOL (216)
DIAZEPAM (185)
CLONAZEPAM (179)
LORAZEPAM (165)
SERTRALINE (163)
Which ARIPIPRAZOLE Alternatives Have Lower Salivary hypersecretion Risk?
ARIPIPRAZOLE vs ARIPIPRAZOLE LAUROXIL
ARIPIPRAZOLE vs ARIXTRA
ARIPIPRAZOLE vs ARMODAFINIL
ARIPIPRAZOLE vs AROMASIN
ARIPIPRAZOLE vs ARSENIC TRIOXIDE